INSMED INC
INSM·457669307·US·Common Stock·Healthcare - Biotechnology-13D/G
INSM (INSMED INC) is held by 276 institutional investors as of Q1 2026. Largest holders: JPMORGAN CHASE & CO ($3.7B), BlackRock, Inc. ($2.7B), FMR LLC ($2.2B). Net institutional sentiment: Mixed. In Q1 2026, 2 members of Congress and 165 funds bought INSM.
276
Holders
(19 Elite)
$29.8B
Total Value
57% (287)
Consensus
165 buying - 122 selling
13F: Insider & Congress:
Who's Trading
InsiderLWLewis WilliamSell $583KJul 9, 2026
InsiderLWLewis WilliamSell $275KJul 9, 2026
InsiderLWLewis WilliamSell $398KJul 9, 2026
InsiderFMFlammer Martina M.D.Sell $529KJul 6, 2026
ActivistDGDarwin Global Management, Ltd.7.8%May 15, 2026
Showing 1-20 of 292
1 / 15
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer